Specific Pharma A/S and Oncoscience GmbH launch a Named Patient Program for the treatment of cancer with nimotuzumab.

Oncoscience | November 6th, 2020

Specific Pharma announced today that it has entered into a supply and distribution collaboration with German based Onc...